Date/Time: Tuesday, February 22nd 2022 at 3:00 p.m. Eastern
Presenter: Dr. Deborah Gelinas, MD, Executive Director of Neuromuscular Medicine for Argenx.
Webinar presentation of newly FDA Approved VYVGART™ (efgartigimod alfa-fcab) for the treatment of adult patients with gMG who are anti-AChR antibody positive
Samm brings more than two decades of nonprofit experience, serving in executive leadership roles for healthcare nonprofits such as March of Dimes, National Brain Tumor Society, and the American Liver Foundation. She has an extensive background in organizational management, strategic planning, board and volunteer development, and revenue generation that results in growth and impact. As MGFA’s senior executive, Samm is responsible for providing the vision and strategy to fulfill the work identified in the organization’s strategic plan, support the MGFA’s vision and mission, and ensure that both the operational and board structures support this work.